Harmonet (Ethinylestradiol, Gestodene)

Harmonet is indicated for the prevention of pregnancy in women of reproductive age. It is used as a hormonal contraceptive to provide reliable cycle control and reduce the risk of unintended conception.

• Primary method of birth control for women seeking a reversible option.
• Suitable for regular menstrual cycle regulation.
• May be prescribed to manage acne related to hormonal fluctuations.
• Can be part of a comprehensive family planning program.
• May be used after childbirth or abortion when medically appropriate.

Side effects of Harmonet vary in frequency and severity. Most are mild and resolve without intervention, while rare serious reactions require medical attention.

Common

• Nausea or mild gastrointestinal upset.
• Headache or migraine episodes.
• Breast tenderness or enlargement.
• Spotting or breakthrough bleeding between periods.
• Weight fluctuations or fluid retention.
• Mood changes or mild depression.

Serious

• Signs of deep vein thrombosis such as leg pain or swelling.
• Sudden shortness of breath or chest pain.
• Severe abdominal pain with vomiting.
• Visual disturbances or severe headache suggesting hypertension.
• Jaundice or liver dysfunction.
• Allergic reactions including rash, swelling, or difficulty breathing.

Before starting Harmonet, certain health considerations should be reviewed with a healthcare professional. The following precautions are commonly advised:

• Do not use if you have a history of thromboembolic disorders, stroke, or myocardial infarction.
• Avoid if you are pregnant, planning pregnancy, or have known estrogen‑dependent tumors.
• Caution in smokers over 35 years of age due to increased cardiovascular risk.
• Discuss any liver disease, hypertension, or diabetes with your prescriber.
• Review all current medications, including over‑the‑counter products, for potential interactions.
• Seek medical advice if you experience persistent severe headaches or visual changes.

Harmonet may interact with other medicines, affecting its efficacy or increasing the risk of side effects. Interaction guidance is divided into two categories.

Avoid

• Strong enzyme inducers such as rifampicin, carbamazepine, phenytoin, and St. John’s wort, which can reduce contraceptive effectiveness.
• Certain antivirals (e.g., protease inhibitors) that may alter hormone levels.
• Medications that increase the risk of clotting, such as selective estrogen receptor modulators.

Use with caution

• Antifungal agents like ketoconazole that may increase hormone concentrations.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that could affect bleeding patterns.
• Herbal supplements that have unknown effects on hormonal pathways.
• Antibiotics that are not known inducers but may cause gastrointestinal upset affecting absorption.